CERV-196 Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MRI-H196 cell line, derived from HPV16-positive cervical carcinoma, displays a unique HPV16 transcript expression profile characterized by the presence of the full-length L1 transcript and a marked absence of the E5 full-length RNA. This pattern suggests an integration of the HPV16 genome within the cell line, particularly affecting the E2 region and causing rearrangement of the L1 DNA sequence. The absence of E5 full-length RNA expression indicates a disruption in the transcription of full-length early RNAs, which typically conclude at the polyadenylation signal located downstream of the E5 open reading frame (ORF). Such a disruption is indicative of the integrated state of HPV16 genomes, where the crucial E2 region-key for viral replication and transcription regulation-is often compromised during the integration into the host genome. This disruption potentially impacts the expression of downstream genes, including E5. This integration phenomenon within MRI-H196 cells highlights the complexity of HPV16 genome behavior post-integration, emphasizing the cell line's utility in studying the genomic and transcriptional intricacies associated with HPV integration in cervical carcinomas. Understanding these dynamics is crucial for insights into the mechanisms of oncogenesis and the progression of HPV-associated cancers, making the MRI-H196 cell line a valuable resource for medical and biological research. |
|---|---|
| Organism | Human |
| Tissue | Cervix |
| Disease | Squamous cell carcinoma |
| Synonyms | Cerv-196, MRI-H-196, MRI-H196 |
Characteristics
| Age | 49 years |
|---|---|
| Gender | Female |
| Ethnicity | African |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | CERV-196 (Cytion catalog number 300291) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_5721 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice |
|---|---|
| Viruses | HPV-16 positive |
| Products | Cytokeratine 8, 18, Vimentin |
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 is recommended |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300291-161225 | Certificate of Analysis | 27. Jan. 2026 | 300291 |
| 300291-111223 | Certificate of Analysis | 23. May. 2025 | 300291 |